Work

Is Targeting the Folate Receptor in Ovarian Cancer Coming of Age?

Year: 2019

Type: article

Abstract: Prognosis for women with epithelial ovarian cancer remains poor. One new molecular target in epithelial ovarian cancer is folate receptor alpha (FRα). This commentary discusses the characteristics that contribute to its attractiveness as a candidate for therapeutic intervention.

Source: The Oncologist

DOI: 10.1634/theoncologist.2018-0459

Authors: Michael J. Birrer, Ilaria Betella, Lainie P. Martin, Kathleen N. Moore

Institutions: University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center, University of Pennsylvania, OU Health Stephenson Cancer Center, University of Oklahoma Health Sciences Center

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2910693133